Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
Aspar Pharmaceuticals Limited has informed the MHRA that the Patient Information Leaflets (PILs) within the ibuprofen packs below are missing some information identified from post-marketing experience that should be documented in Section 3 (How To Take The Tablets) and Section 4 (Possible Side Effects) of the PIL.
This circular is being shared under the Open Government Copyright licence. Whilst we will publish alerts relevant to pharmacists, pharmacy technicians and pharmacy teams we recommend you also keep an eye on the SHOW website.
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.